Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
WST logo

West Pharmaceutical Profits Rise 10.6% Driven by High-Value Injectable Components

WST10-KFiling Date: 2/17/2026
West Pharmaceutical Services Inc
Description

What this story covers

West Pharmaceutical Services delivered a strong 2025, with a 10.6% gross profit increase fueled by demand for high-value injectable components. Despite restructuring costs and legal challenges, the company maintains robust liquidity and a strategic focus on biologic delivery.

Story snapshot

CompanyWest Pharmaceutical Services Inc
TickerWST
VariantStandard detailed
Duration12:32
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000105770-26-000010
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in